ValiRx Plc Stock London S.E.
Equities
GB00B23N9136
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-16 | EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target | AN |
05-15 | Vertu Motors ups dividend as hails record revenue | AN |
Sales 2023 | 9.6K 12.19K 16.59K | Sales 2024 * | - | Capitalization | 2.51M 3.19M 4.34M |
---|---|---|---|---|---|
Net income 2023 | -2M -2.54M -3.46M | Net income 2024 * | - | EV / Sales 2023 | 791 x |
Net cash position 2023 * | 1.8M 2.29M 3.11M | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | - |
P/E ratio 2023 |
-2.94
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 83.27% |
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Chief Tech/Sci/R&D Officer | - | 22-09-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 06-08-31 |
Kevin Cox
CHM | Chairman | 65 | 20-06-25 |
Director/Board Member | 57 | 02-28 |
1st Jan change | Capi. | |
---|---|---|
+8.71% | 114B | |
+11.13% | 104B | |
-12.73% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.08% | 17.89B | |
+7.73% | 14.28B | |
+35.20% | 12.55B |